Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
Contact us for detailed pricing information tailored to your specific needs and requirements.
Our team at Tradewind BioScience is dedicated to developing drugs that target the most aggressive cancers. Formed by founders with deep scientific expertise, we bring a wealth of knowledge, proprietary assays, and a focus on biomarker identification to ensure our medicines make a significant impact on patient outcomes.
Cancer targeting attack particles
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Blood Test for Early Detection of Ovarian Cancer
Adventris makes cancer vaccines
mRNA Immunotherapies to Eliminate Cancer
We use AI to design antibodies for intractable diseases
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS